Product Information
SUMATRIPTAN 6 MG/0.5 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $15.0000 per ML under NDC 63323027301. Its NADAC has been published 103 times since Apr 23, 2014.
FDA first approved this application on Mar 2, 2009. Its Orange Book therapeutic-equivalence code is AP.
Strength
6 mg/.5mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323027301
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
7/22/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA079242FDA Approved
3/2/2009
TE Code
AP
On Market Since
4/12/2011
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has been published 103 times since Apr 23, 2014, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.0000 per ML |
|---|---|
| All-time high | $105.0240 (Jun 3, 2015) |
| All-time low | $14.4040 (Oct 22, 2025) |
| 52-week high | $15.0000 |
| 52-week low | $14.4040 |
| Median price | $105.0240 |
| Average price | $66.5064 |
| Largest weekly change | -86.3% (Oct 22, 2025) |
| Weeks tracked | 103 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $15.0000 per ML (NDC 63323027301), effective Aug 19, 2026.
How has the price of SUMATRIPTAN 6 MG/0.5 ML VIAL changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has declined 85.7%. It has been tracked across 103 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML VIAL?
Since Apr 23, 2014, the NADAC for SUMATRIPTAN 6 MG/0.5 ML VIAL has ranged from a low of $14.4040 (Oct 22, 2025) to a high of $105.0240 (Jun 3, 2015), with a median of $105.0240 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUMATRIPTAN 6 MG/0.5 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML VIAL?
SUMATRIPTAN 6 MG/0.5 ML VIAL (NDC 63323027301) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.